Artificial intelligence for cancer-associated thrombosis risk assessment. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Artificial intelligence for cancer-associated thrombosis risk assessment.

Patrizia Ferroni, Mario Roselli, Fabio M Zanzotto, Fiorella Guadagni

Author Information

Patrizia Ferroni: Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, Rome 00166, Italy; InterInstitutional Multidisciplinary Biobank, IRCCS San Raffaele Pisana, Rome, Italy. Electronic address: patrizia.ferroni@sanraffaele.it.
Mario Roselli: Department of Systems Medicine, Medical Oncology, Policlinico Tor Vergata Biospecimen Cancer Repository, University of Rome Tor Vergata, Rome, Italy.
Fabio M Zanzotto: Department of Enterprise Engineering, University of Rome Tor Vergata, Rome, Italy.
Fiorella Guadagni: Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, Rome 00166, Italy; InterInstitutional Multidisciplinary Biobank, IRCCS San Raffaele Pisana, Rome, Italy.

PMID: 30172343 DOI: 10.1016/S2352-3026(18)30111-X

No abstract text available.

Artificial Intelligence

Humans

Neoplasms

Risk Assessment

Thrombosis

Letter Comment

Artificial intelligence for cancer-associated thrombosis risk assessment - Author's reply.Artificial Intelligence for Breast Cancer Risk Assessment.Artificial Intelligence for chemical risk assessment.Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence.Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.Artificial intelligence and cardiac surgery risk assessment.Ethics, Artificial Intelligence, and Risk Assessment.Artificial Intelligence (AI) and periodontal risk assessment.From CT to artificial intelligence for complex assessment of plaque-associated risk.Risk assessment for thrombosis in cancer.

Breast Cancer Prognosis Using a Machine Learning Approach.Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey.Machine learning approach to predict medication overuse in migraine patients.Artificial Intelligence Evidence-Based Current Status and Potential for Lower Limb Vascular Management.Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care.A review of genetic variant databases and machine learning tools for predicting the pathogenicity of breast cancer.Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models.